Training future cancer researchers in genomics and precision medicine
Translational Genomics and Precision Medicine in Cancer Training Program
['FUNDING_TRAINING'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-10848855
This program is designed to help new researchers learn how to use big data and genetics to improve cancer care, so they can turn their research into real treatments for patients like you.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10848855 on ClinicalTrials.gov |
What this research studies
This program focuses on training the next generation of researchers in the field of cancer by emphasizing the importance of genomic medicine and big data. It aims to equip predoctoral and postdoctoral fellows with the skills needed to translate research findings into clinical practice. The training includes a comprehensive curriculum that covers key areas such as early detection, prognosis, and diagnostic applications in cancer. Participants will benefit from a supportive and innovative environment at MD Anderson Cancer Center, which is dedicated to eliminating cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals pursuing careers in translational cancer research, particularly those interested in genomics and precision medicine.
Not a fit: Patients who are not involved in academic or research careers in cancer may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments and outcomes through enhanced training of researchers in precision medicine.
How similar studies have performed: Similar training programs have shown success in advancing cancer research and improving clinical practices, indicating a strong potential for this approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KILLARY, ANN M — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: KILLARY, ANN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer